Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne.
Integrative Skin Science and Research · with Almirall, S.A. · NCT07544251
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 9+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 4
- Target enrollment
- 30
- US sites recruiting
- 1
- Study start
- April 20, 2026
- Record last updated
- April 22, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study is being done to help better understand how the gut and skin bacteria of the body change when people with acne are treated with Sarecycline or Doxycycline. The bacteria in the gut and on the skin will be studied to see how each treatment may affect them and whether they change the profile of the bacteria that is present.
Being studied: Sarecycline; Doxycycline
Conditions: Acne Vulgaris
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Diagnosis of acne vulgaris with:
- At least 10 inflammatory lesions (papules, pustules, and nodules) up to 100 noninflammatory lesions (open and closed comedones)
- No more than 2 nodules on the face
Exclusion Criteria
- Dermatological condition of face or facial hair that could interfere with clinical evaluations
- Subjects who have used the following medications (topical refers only to the facial area) will not be eligible:
2a) Within 2 week prior to randomization:
- Topical acne medications such as retinoids, antibiotics, hormonal modulators
- Topical benzoyl peroxide
- Topical anti-inflammatories and corticosteroids
2b) Within 4 weeks prior to randomization:
- Systemic antibiotics
- Systemic acne treatments
- Oral probiotic supplement
- Systemic corticosteroids
2c) Within 12 weeks prior to randomization:
- Systemic retinoids
- Individuals who have changed any of their hormonal based contraception or therapies within 3 months prior to joining the study.
- Individuals who are pregnant or breastfeeding.
- Individuals on oral contraceptive pills or progesterone or estrogen containing therapies unless they have been on a stable dose for 2 months.
- Individuals on finasteride or dutasteride
- Current tobacco smoker or a tobacco smoking history that is greater than 5 pack-years.
Recruiting US locations
Integrative Research Institute
Sacramento, CA 95819
Site contact: Nasima Afzal Chief Operating Officer · 209-607-8778 · nasima@integrativeskinresearch.com
Study contacts (from the official record)
- Nasima Afzal Chief Operating Officer · 916-775-5080 · nasima@integrativeskinresearch.com
Similar studies in California
All dermatology studies in California →- RecruitingHealthy volunteersPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Regeneron Pharmaceuticals
- Location
- West Hills, CA + 5 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
Bambusa Therapeutics
- Location
- Irvine, CA + 2 other US sites
- Eligibility basics
- Ages 18–72
- RecruitingHealthy volunteersPhase 1
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
Pfizer
- Location
- Anaheim, CA + 4 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1
A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis
Sitryx Therapeutics Ltd
- Location
- Fremont, CA + 5 other US sites
- Eligibility basics
- Ages 18–65